METMAX-GM1
Glimepiride and Metformin Hydrochloride Prolonged-Release Tablets IP
METMAX-GM1 is a premium anti-diabetic formulation from Max Pharma, combining Glimepiride 1mg with Metformin Hydrochloride 500mg SR. This dual-action medication supports better glycemic control in patients with Type 2 Diabetes Mellitus, especially those not adequately controlled by diet, exercise, or monotherapy alone.
The Glimepiride component stimulates pancreatic insulin release, while Metformin SR improves insulin sensitivity and reduces hepatic glucose production—offering a balanced and effective approach to managing blood sugar levels.
Key Features of METMAX-GM1 by Max Pharma:
Ideal for early-stage Type 2 diabetic patients
Sustained-release Metformin ensures better gastrointestinal tolerability
Low-dose Glimepiride minimizes hypoglycemia risk
Manufactured under GMP-certified facilities by Max Pharma for consistent quality and efficacy
Recommended Usage:
One tablet daily or as prescribed by a physician. Preferably taken with food.
Precautions:
Regular blood glucose monitoring is advised. Not recommended for Type 1 diabetes or patients with severe renal impairment.
For more trusted and high-quality antidiabetic medications, explore the full Tablet Range by Max Pharma.
Reviews
There are no reviews yet.